209 related articles for article (PubMed ID: 29024742)
21. Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases.
Korobkova EA
Chem Res Toxicol; 2015 Jul; 28(7):1359-90. PubMed ID: 26042469
[TBL] [Abstract][Full Text] [Related]
22. The Effects of CKD on Cytochrome P450-Mediated Drug Metabolism.
Ladda MA; Goralski KB
Adv Chronic Kidney Dis; 2016 Mar; 23(2):67-75. PubMed ID: 26979145
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoids and Cytochrome P450 Interactions.
Zendulka O; Dovrtělová G; Nosková K; Turjap M; Šulcová A; Hanuš L; Juřica J
Curr Drug Metab; 2016; 17(3):206-26. PubMed ID: 26651971
[TBL] [Abstract][Full Text] [Related]
24. Altered cytochrome P450 activities and expression levels in the liver and intestines of the monosodium glutamate-induced mouse model of human obesity.
Tomankova V; Liskova B; Skalova L; Bartikova H; Bousova I; Jourova L; Anzenbacher P; Ulrichova J; Anzenbacherova E
Life Sci; 2015 Jul; 133():15-20. PubMed ID: 25998026
[TBL] [Abstract][Full Text] [Related]
25. The current understanding of the interactions between nanoparticles and cytochrome P450 enzymes - a literature-based review.
Pan Y; Ong CE; Pung YF; Chieng JY
Xenobiotica; 2019 Jul; 49(7):863-876. PubMed ID: 30028220
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.
Neve EP; Ingelman-Sundberg M
Curr Opin Drug Discov Devel; 2010 Jan; 13(1):78-85. PubMed ID: 20047148
[TBL] [Abstract][Full Text] [Related]
27. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of cerebral and hepatic cytochrome P450s alters behavioral activity of rat offspring following prenatal exposure to lindane.
Johri A; Yadav S; Dhawan A; Parmar D
Toxicol Appl Pharmacol; 2007 Dec; 225(3):278-92. PubMed ID: 17919674
[TBL] [Abstract][Full Text] [Related]
29. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
[TBL] [Abstract][Full Text] [Related]
30. Roles of maize cytochrome P450 (CYP) enzymes in stereo-selective metabolism of hexabromocyclododecanes (HBCDs) as evidenced by in vitro degradation, biological response and in silico studies.
Huang H; Wang D; Wen B; Lv J; Zhang S
Sci Total Environ; 2019 Mar; 656():364-372. PubMed ID: 30513427
[TBL] [Abstract][Full Text] [Related]
31. Circulating Extracellular Vesicles Containing Xenobiotic Metabolizing CYP Enzymes and Their Potential Roles in Extrahepatic Cells Via Cell-Cell Interactions.
Gerth K; Kodidela S; Mahon M; Haque S; Verma N; Kumar S
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817878
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
Zanger UM; Schwab M
Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
[TBL] [Abstract][Full Text] [Related]
33. The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders.
Haduch A; Daniel WA
Drug Metab Rev; 2018 Nov; 50(4):415-429. PubMed ID: 30501426
[TBL] [Abstract][Full Text] [Related]
34. Consequences of psychophysiological stress on cytochrome P450-catalyzed drug metabolism.
Konstandi M; Johnson EO; Lang MA
Neurosci Biobehav Rev; 2014 Sep; 45():149-67. PubMed ID: 24877684
[TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450-activated prodrugs: targeted drug delivery.
Huttunen KM; Mähönen N; Raunio H; Rautio J
Curr Med Chem; 2008; 15(23):2346-65. PubMed ID: 18855665
[TBL] [Abstract][Full Text] [Related]
36. Structural insights into understudied human cytochrome P450 enzymes.
Machalz D; Pach S; Bermudez M; Bureik M; Wolber G
Drug Discov Today; 2021 Oct; 26(10):2456-2464. PubMed ID: 34161845
[TBL] [Abstract][Full Text] [Related]
37. Induction of cytochrome P450 enzymes in primary equine hepatocyte culture.
Stefanski A; Mevissen M; Möller AM; Kuehni-Boghenbor K; Schmitz A
Toxicol In Vitro; 2013 Oct; 27(7):2023-30. PubMed ID: 23916975
[TBL] [Abstract][Full Text] [Related]
38. The role of brain noradrenergic system in the regulation of liver cytochrome P450 expression.
Sadakierska-Chudy A; Haduch A; Rysz M; Gołembiowska K; Daniel WA
Biochem Pharmacol; 2013 Sep; 86(6):800-7. PubMed ID: 23924605
[TBL] [Abstract][Full Text] [Related]
39. Role of Cytochrome P450 Monooxygenase in Carcinogen and Chemotherapeutic Drug Metabolism.
Wahlang B; Falkner KC; Cave MC; Prough RA
Adv Pharmacol; 2015; 74():1-33. PubMed ID: 26233902
[TBL] [Abstract][Full Text] [Related]
40. Cytochrome P450-mediated metabolism in the human gut wall.
Thelen K; Dressman JB
J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
